Pharmafile Logo
Pharmafocus logo
Advanced Search
782px-golden_hamster_front_1

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters

September 4, 2020
Medical Communications COVID-19, J&J, JJ

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters.

News
shutterstock_159488225

Akebia Therapeutics’ HIF-PH inhibitor passes efficacy goals in chronic kidney disease without dialysis, but falls short on safety

September 4, 2020
Medical Communications, Research and Development Akebia Therapeutics, kidney disease, pharma, vadadustat

Akebia Therapeutics has pulled back the veil on data from the second of two Phase 3 clinical trials for its …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 4, 2020
Medical Communications

The top 10 news stories this week largely cover coronavirus, as Sanofi is halting clinical trials treating serious COVID-19 patients …

News

NICE knocks back Janssen’s Spravato nasal spray for the second time in treatment-resistant depression

September 3, 2020
Sales and Marketing Janssen, Spravato, depression, pharma

NICE has opted to reject Janssen’s nasal spray Spravato (esketamine) for routine use on the NHS for treatment-resistant major depressive …

News
img_4190-e1376666350337-web

MHRA gives OK to Bavencio for first-line maintenance of advanced bladder cancer via the Early Access to Medicines Scheme

September 3, 2020
Sales and Marketing Bavencio, MHRA, Merck, Pfizer, UK, eams, pharma

It has been revealed that Bavencio (avelumab), jointly developed by Merck KGaA and Pfizer, has been approved by the UK …

News
gustave_perna_29510410783

Four COVID-19 vaccine trials backed by Operation Warp Speed will likely fail, according to a new report

September 3, 2020
Research and Development

Four late-stage trials of vaccine candidates partly funded by the US Operation Warp Speed are likely to fail, according to …

News
800px-ted_cruz_39609752645

Ted Cruz and 19 other GOP Senators ask FDA to remove Danco’s abortion drug Mifeprex from the market

September 3, 2020
Manufacturing and Production Mifeprex, abortion

Texas Senator Ted Cruz and 19 other senators have sent a letter to the FDA urging them to take the …

News
tiktok-5323005_960_720

J&J issues warning after teen dies from Benadryl TikTok challenge

September 3, 2020
Medical Communications

One teen has died after taking large amounts of the antihistamine Benadryl as part of a social media “challenge” on …

News
shutterstock_138095450

Gilead and Jounce Therapeutics forge immuno-oncology partnership worth a potential $700m+

September 2, 2020
Research and Development, Sales and Marketing Gilead, jounce, oncology, pharma

Gilead and Jounce Therapeutics have come together in a new immuno-oncology partnership potentially worth over $700 million. The primary drive …

News
800px-president_trump_delivers_remarks_at_the_white_house_coronavirus_task_force_briefing_49716740721

US won’t join COVAX coronavirus vaccine initiative because it is linked to the WHO

September 2, 2020
Research and Development Trump, Trump Administration, US, USA

The US has said it will not participate in an international effort to develop and distribute a coronavirus vaccine.COVAX is …

News
type_2_diabetes_28081593711_1

Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK

September 2, 2020
Research and Development Novo Nordisk, diabetes, type 2, type 2 diabetes

Novo Nordisk’s new type 2 diabetes treatment Rybelsus is now available for doctors and physicians in the UK to prescribe …

News
shutterstock_273326141

Nestlé to acquire remaining shares in Aimmune for $2.6 billion

September 2, 2020
Research and Development, Sales and Marketing Aimmune, acquisition, nestle, pharma

Food and drink giant Nestlé has confirmed it is in motion to scoop up the remaining shares in Californian biotech …

News
covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

September 2, 2020
Research and Development

The COVID-19 news round-up this week focuses on coronavirus treatments, with Celltrion Group announcing that the Korean Ministry of Food …

News
index_ph001

Daiichi Sankyo’s Nilemdo “significantly” reduces cholesterol levels at ESC 2020

September 1, 2020
Manufacturing and Production, Research and Development Daiichi Sankyo, Nilemdo, pharma

Daiichi Sankyo has unveiled promising new benefit for Nilemdo (bempedoic acid) at the ESC Congress 2020 over the weekend for …

News
flu_vaccination_grippe_5115654021

Oxford University’s COVID-19 vaccine begins Phase 3 trial in the US

September 1, 2020
Manufacturing and Production

AstraZeneca has started a Phase 3 trial of its experimental coronavirus vaccines in the US, making it the third company …

News
800px-street_in_hong_kong_during_the_covid-19_pandemic

Hong Kong rolls out free universal coronavirus testing programme

September 1, 2020
Manufacturing and Production

Hong Kong has begun a free universal COVID-19 testing programme to help combat the coronavirus.  This mass testing system will …

News
800px-vaccine

Sanofi halts Phase 3 trial of Kevzara as a COVID-19 treatment

September 1, 2020
Manufacturing and Production COVID-19, Sanofi, Vaccine, pharma

Sanofi is halting clinical trials treating serious COVID-19 patients with its Kevzara drug after data on its efficacy proved inconclusive.The …

News
astrazeneca_plaque

AstraZeneca’s Farxiga combo shows promise at Phase 3 in late-stage chronic kidney disease

September 1, 2020
Manufacturing and Production AstraZeneca, ESC Congress 2020, pharma

AstraZeneca took the opportunity at the digital ESC Congress 2020 over the weekend to reveal promising new Phase 3 data …

News
3dmammogram

University of Illinois at Chicago’s new breast cancer drug is safe and can halt disease progression, according to a Phase 1 trial

August 28, 2020
Medical Communications Cancer, Cancers, breast cancer

A new breast cancer drug, called TTC-352, can halt the spread of the disease and is safe according to a …

News
49720569077_fac396d536_b

US signs deal to buy 150 million rapid COVID-19 tests from Abbott

August 28, 2020
Medical Communications

The US government has signed a deal to buy Abbott’s rapid coronavirus test after the FDA gave it Emergency Use …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026